Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Bioptimus, a Paris-based startup focused on developing a foundational AI model for biology, has successfully raised $41 million in a funding round led by Cathay Innovation. This latest investment brings the company's total funding to $76 million, achieved in less than 12 months since its seed round. The startup aims to launch the world's first universal AI foundation model for biology, which is expected to revolutionize fields such as biotechnology, medicine, and cosmetics. Following the launch of the largest AI foundation model for pathology in July 2024, Bioptimus is preparing for further advancements in 2025.
๐BC Tech member and two-time Technology Impact Award winner, @aspectbiosys has secured US$115 Million in Series B funding to advance their groundbreaking bioprinted tissue therapeutics. ๐ Read more about this incredible milestone here! https://t.co/MwelHcAEMU
Bioptimus adds $41m to build โthe GPT of biologyโ French AI startup expects to launch first multi-scale, multi-modal foundation model for biology in 2025. #longevity #investment #AI #biology https://t.co/lH9yTB1qTC https://t.co/lqBFOn2ccx
๐๐ถ๐ผ๐ฝ๐๐ถ๐บ๐๐: ๐ง๐ต๐ฒ ๐๐ฃ๐ง ๐ณ๐ผ๐ฟ ๐๐ถ๐ผ๐น๐ผ๐ด๐ ๐ฎ๐ป๐ฑ ๐๐๐ ๐ฃ๐ผ๐๐ฒ๐ป๐๐ถ๐ฎ๐น ๐๐บ๐ฝ๐ฎ๐ฐ๐ ๐ Bioptimus secures $76M funding to launch the worldโs first universal AI foundation model for biology! ๐๐ฌ Revolutionizing biotech, medicine, and cosmetics withโฆ https://t.co/bL0EWlov7w
